{
  "id": [
    "31543249"
  ],
  "source": [
    "MED"
  ],
  "pmid": [
    "31543249"
  ],
  "pmcid": [
    "PMC6892259"
  ],
  "doi": [
    "10.1016/s1473-3099(19)30323-8"
  ],
  "title": [
    "Long-term immunity against yellow fever in children vaccinated during infancy: a longitudinal cohort study."
  ],
  "authorString": [
    "Domingo C, Fraissinet J, Ansah PO, Kelly C, Bhat N, Sow SO, Mejía JE."
  ],
  "authorList": [
    {
      "author": [
        {
          "fullName": [
            "Domingo C"
          ],
          "firstName": [
            "Cristina"
          ],
          "lastName": [
            "Domingo"
          ],
          "initials": [
            "C"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Robert Koch Institute, Highly Pathogenic Viruses (ZBS 1), Centre for Biological Threats and Special Pathogens, WHO Collaborating Centre for Emerging Infections and Biological Threats, Berlin, Germany. Electronic address: domingo-carrascoc@rki.de."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Fraissinet J"
          ],
          "firstName": [
            "Juliane"
          ],
          "lastName": [
            "Fraissinet"
          ],
          "initials": [
            "J"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Robert Koch Institute, Highly Pathogenic Viruses (ZBS 1), Centre for Biological Threats and Special Pathogens, WHO Collaborating Centre for Emerging Infections and Biological Threats, Berlin, Germany."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Ansah PO"
          ],
          "firstName": [
            "Patrick O"
          ],
          "lastName": [
            "Ansah"
          ],
          "initials": [
            "PO"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Navrongo Health Research Centre and Research Laboratory, Navrongo, Ghana."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Kelly C"
          ],
          "firstName": [
            "Corey"
          ],
          "lastName": [
            "Kelly"
          ],
          "initials": [
            "C"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "PATH, Seattle, WA, USA."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Bhat N"
          ],
          "firstName": [
            "Niranjan"
          ],
          "lastName": [
            "Bhat"
          ],
          "initials": [
            "N"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "PATH, Seattle, WA, USA."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Sow SO"
          ],
          "firstName": [
            "Samba O"
          ],
          "lastName": [
            "Sow"
          ],
          "initials": [
            "SO"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "National Institute of Research on Public Health, Bamako, Mali."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Mejía JE"
          ],
          "firstName": [
            "José E"
          ],
          "lastName": [
            "Mejía"
          ],
          "initials": [
            "JE"
          ],
          "authorId": [
            {
              "_": "0000-0002-2208-8870",
              "$": {
                "type": "ORCID"
              }
            }
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Centre de Physiopathologie Toulouse-Purpan (CNRS, INSERM, Université Paul Sabatier), Centre Hospitalier Universitaire Purpan, Toulouse, France."
              ]
            }
          ]
        }
      ]
    }
  ],
  "authorIdList": [
    {
      "authorId": [
        {
          "_": "0000-0002-2208-8870",
          "$": {
            "type": "ORCID"
          }
        }
      ]
    }
  ],
  "dataLinksTagsList": [
    {
      "dataLinkstag": [
        "full_text",
        "altmetrics"
      ]
    }
  ],
  "journalInfo": [
    {
      "issue": [
        "12"
      ],
      "volume": [
        "19"
      ],
      "journalIssueId": [
        "2885965"
      ],
      "dateOfPublication": [
        "2019 Dec"
      ],
      "monthOfPublication": [
        "12"
      ],
      "yearOfPublication": [
        "2019"
      ],
      "printPublicationDate": [
        "2019-12-01"
      ],
      "journal": [
        {
          "title": [
            "The Lancet. Infectious diseases"
          ],
          "ISOAbbreviation": [
            "Lancet Infect Dis"
          ],
          "medlineAbbreviation": [
            "Lancet Infect Dis"
          ],
          "NLMid": [
            "101130150"
          ],
          "ISSN": [
            "1473-3099"
          ],
          "ESSN": [
            "1474-4457"
          ]
        }
      ]
    }
  ],
  "pubYear": [
    "2019"
  ],
  "pageInfo": [
    "1363-1370"
  ],
  "abstractText": [
    "BACKGROUND:A single dose of vaccine against yellow fever is routinely administered to infants aged 9-12 months under the Expanded Programme on Immunization, but the long-term outcome of vaccination in this age group is unknown. We aimed to evaluate the long-term persistence of neutralising antibodies to yellow fever virus following routine vaccination in infancy. METHODS:We did a longitudinal cohort study, using a microneutralisation assay to measure protective antibodies against yellow fever in Malian and Ghanaian children vaccinated around age 9 months and followed up for 4·5 years (Mali), or 2·3 and 6·0 years (Ghana). Healthy children with available day-0 sera, a complete follow-up history, and no record of yellow fever revaccination were included; children seropositive for yellow fever at baseline were excluded. We standardised antibody concentrations with reference to the yellow fever WHO International Standard. FINDINGS:We included 587 Malian and 436 Ghanaian children vaccinated between June 5, 2009, and Dec 26, 2012. In the Malian group, 296 (50·4%, 95% CI 46·4-54·5) were seropositive (antibody concentration ≥0·5 IU/mL) 4·5 years after vaccination. Among the Ghanaian children, 121 (27·8%, 23·5-32·0) were seropositive after 2·3 years. These results show a large decrease from the proportions of seropositive infants 28 days after vaccination, 96·7% in Mali and 72·7% in Ghana, reported by a previous study of both study populations. The number of seropositive children increased to 188 (43·1%, 95% CI 38·5-47·8) in the Ghanaian group 6·0 years after vaccination, but this result might be confounded by unrecorded revaccination or natural infection with wild yellow fever virus during a 2011-12 outbreak in northern Ghana. INTERPRETATION:Rapid waning of immunity during the early years after vaccination of 9-month-old infants argues for a revision of the single-dose recommendation for this target population in endemic countries. The short duration of immunity in many vaccinees suggests that booster vaccination is necessary to meet the 80% population immunity threshold for prevention of yellow fever outbreaks. FUNDING:Wellcome Trust."
  ],
  "affiliation": [
    "Robert Koch Institute, Highly Pathogenic Viruses (ZBS 1), Centre for Biological Threats and Special Pathogens, WHO Collaborating Centre for Emerging Infections and Biological Threats, Berlin, Germany. Electronic address: domingo-carrascoc@rki.de."
  ],
  "publicationStatus": [
    "ppublish"
  ],
  "language": [
    "eng"
  ],
  "pubModel": [
    "Print-Electronic"
  ],
  "pubTypeList": [
    {
      "pubType": [
        "Research Support, Non-U.S. Gov't",
        "research-article",
        "Journal Article"
      ]
    }
  ],
  "meshHeadingList": [
    {
      "meshHeading": [
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Humans"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Yellow fever virus"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "IM"
                  ],
                  "qualifierName": [
                    "immunology"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Yellow Fever"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "IM"
                  ],
                  "qualifierName": [
                    "immunology"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                },
                {
                  "abbreviation": [
                    "PC"
                  ],
                  "qualifierName": [
                    "prevention & control"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Yellow Fever Vaccine"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "AD"
                  ],
                  "qualifierName": [
                    "administration & dosage"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Antibodies, Viral"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "BL"
                  ],
                  "qualifierName": [
                    "blood"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "IM"
                  ],
                  "qualifierName": [
                    "immunology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "Y"
          ],
          "descriptorName": [
            "Vaccination"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Prevalence"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Longitudinal Studies"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Age Factors"
          ]
        },
        {
          "majorTopic_YN": [
            "Y"
          ],
          "descriptorName": [
            "Immunity"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Time Factors"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Infant"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Mali"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "EP"
                  ],
                  "qualifierName": [
                    "epidemiology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Female"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Male"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Antibodies, Neutralizing"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "BL"
                  ],
                  "qualifierName": [
                    "blood"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "IM"
                  ],
                  "qualifierName": [
                    "immunology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        }
      ]
    }
  ],
  "chemicalList": [
    {
      "chemical": [
        {
          "name": [
            "Antibodies, Viral"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Yellow Fever Vaccine"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Antibodies, Neutralizing"
          ],
          "registryNumber": [
            "0"
          ]
        }
      ]
    }
  ],
  "subsetList": [
    {
      "subset": [
        {
          "code": [
            "IM"
          ],
          "name": [
            "Index Medicus"
          ]
        }
      ]
    }
  ],
  "fullTextUrlList": [
    {
      "fullTextUrl": [
        {
          "availability": [
            "Subscription required"
          ],
          "availabilityCode": [
            "S"
          ],
          "documentStyle": [
            "doi"
          ],
          "site": [
            "DOI"
          ],
          "url": [
            "https://doi.org/10.1016/S1473-3099(19)30323-8"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "html"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "https://europepmc.org/articles/PMC6892259"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "doi"
          ],
          "site": [
            "DOI"
          ],
          "url": [
            "https://doi.org/10.1016/s1473-3099(19)30323-8"
          ]
        }
      ]
    }
  ],
  "commentCorrectionList": [
    {
      "commentCorrection": [
        {
          "id": [
            "31543248"
          ],
          "source": [
            "MED"
          ],
          "reference": [
            "Lancet Infect Dis. 2019 Dec;19(12):1275-1276"
          ],
          "type": [
            "Comment in"
          ],
          "orderIn": [
            "1"
          ]
        },
        {
          "id": [
            "32006501"
          ],
          "source": [
            "MED"
          ],
          "reference": [
            "Lancet Infect Dis. 2020 Feb;20(2):166-167"
          ],
          "type": [
            "Comment in"
          ],
          "orderIn": [
            "2"
          ]
        }
      ]
    }
  ],
  "isOpenAccess": [
    "Y"
  ],
  "inEPMC": [
    "Y"
  ],
  "inPMC": [
    "N"
  ],
  "hasPDF": [
    "N"
  ],
  "hasBook": [
    "N"
  ],
  "hasSuppl": [
    "Y"
  ],
  "citedByCount": [
    "1"
  ],
  "hasData": [
    "N"
  ],
  "hasReferences": [
    "Y"
  ],
  "hasTextMinedTerms": [
    "Y"
  ],
  "hasDbCrossReferences": [
    "N"
  ],
  "hasLabsLinks": [
    "Y"
  ],
  "license": [
    "cc by"
  ],
  "authMan": [
    "N"
  ],
  "epmcAuthMan": [
    "N"
  ],
  "nihAuthMan": [
    "N"
  ],
  "hasTMAccessionNumbers": [
    "N"
  ],
  "dateOfCompletion": [
    "2020-06-15"
  ],
  "dateOfCreation": [
    "2019-09-24"
  ],
  "firstIndexDate": [
    "2019-09-24"
  ],
  "fullTextReceivedDate": [
    "2019-12-20"
  ],
  "dateOfRevision": [
    "2020-06-15"
  ],
  "electronicPublicationDate": [
    "2019-09-19"
  ],
  "firstPublicationDate": [
    "2019-09-19"
  ]
}